APT Medical Inc. (SHA:688617)

Market Cap	37.81B
Revenue (ttm)	2.07B
Net Income (ttm)	673.48M
Shares Out	96.94M
EPS (ttm)	6.96
PE Ratio	56.03
Forward PE	41.02
Dividend	1.38 (0.35%)
Ex-Dividend Date	n/a

Volume	229,986
Average Volume	513,469
Open	392.51
Previous Close	393.00
Day's Range	388.76 - 396.85
52-Week Range	286.26 - 480.00
Beta	-0.33
RSI	60.82
Earnings Date	Apr 23, 2025

About APT Medical

APT Medical Inc. engages in the research, development, manufacturing, and supply of electrophysiology and vascular interventional medical devices in China. The company offers electrophysiological products comprising mapping catheters, ablation catheters, transseptal needle and sheaths, and steerable sheaths; and interventional cardiology and peripheral intervention products, such as introducer kits, guiding extension catheters, balloon catheters, guiding catheters, microcatheters, guidewires, hydrophilic angiographic catheters, hydrophilic guid...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 2,155
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688617

Financial Performance

In 2024, APT Medical's revenue was 2.07 billion, an increase of 25.18% compared to the previous year's 1.65 billion. Earnings were 673.48 million, an increase of 26.14%.